ALPHA CAPITAL AKTIENGESELLSCHAFT 13D/13G Filings for Benitec Biopharma Inc. (BNTC)

ALPHA CAPITAL AKTIENGESELLSCHAFT 13D and 13G filings for Benitec Biopharma Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-01-13
10:53 am
Sale
2021-12-31 13G Benitec Biopharma Inc.
BNTC
ALPHA CAPITAL AKTIENGESELLSCHAFT 7,333
1.530%
-7,741decrease
(-51.35%)
Filing
2021-01-19
3:18 pm
Sale
2020-12-31 13G Benitec Biopharma Inc.
BNTC
ALPHA CAPITAL AKTIENGESELLSCHAFT 15,075
5.820%
-8,645decrease
(-36.45%)
Filing
2020-10-13
06:23 am
Purchase
2020-10-06 13G Benitec Biopharma Inc.
BNTC
ALPHA CAPITAL AKTIENGESELLSCHAFT 23,719
9.178%
23,719increase
(New Position)
Filing